Annual Working Capital
$113.11 M
+$79.48 M+236.37%
December 31, 2023
Summary
- As of February 7, 2025, TSHA annual working capital is $113.11 million, with the most recent change of +$79.48 million (+236.37%) on December 31, 2023.
- During the last 3 years, TSHA annual working capital has fallen by -$137.64 million (-54.89%).
- TSHA annual working capital is now -54.89% below its all-time high of $250.75 million, reached on December 31, 2020.
Performance
TSHA Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Working Capital
$132.22 M
-$12.07 M-8.37%
September 30, 2024
Summary
- As of February 7, 2025, TSHA quarterly working capital is $132.22 million, with the most recent change of -$12.07 million (-8.37%) on September 30, 2024.
- Over the past year, TSHA quarterly working capital has increased by +$140.86 million (+1629.62%).
- TSHA quarterly working capital is now -50.59% below its all-time high of $267.61 million, reached on September 30, 2020.
Performance
TSHA Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Working Capital Formula
Working Capital = Current Assets − Current Liabilities
TSHA Working Capital Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +236.4% | +1629.6% |
| 3 y3 years | -54.9% | -14.1% |
| 5 y5 years | +10000.0% | - |
TSHA Working Capital Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +236.4% | -8.4% | +1629.6% |
| 5 y | 5-year | -54.9% | >+9999.0% | -50.6% | +1604.0% |
| alltime | all time | -54.9% | >+9999.0% | -50.6% | +1604.0% |
Taysha Gene Therapies Working Capital History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $132.22 M(-8.4%) |
| Jun 2024 | - | $144.29 M(+56.9%) |
| Mar 2024 | - | $91.96 M(-18.7%) |
| Dec 2023 | $113.11 M(+236.4%) | $113.11 M(-1408.6%) |
| Sep 2023 | - | -$8.64 M(-348.8%) |
| Jun 2023 | - | $3.47 M(-80.6%) |
| Mar 2023 | - | $17.90 M(-46.8%) |
| Dec 2022 | $33.63 M | $33.63 M(+240.9%) |
| Sep 2022 | - | $9.86 M(-70.9%) |
| Jun 2022 | - | $33.88 M(-41.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | $58.27 M(-46.0%) |
| Dec 2021 | $107.86 M(-57.0%) | $107.86 M(-29.9%) |
| Sep 2021 | - | $153.96 M(-13.9%) |
| Jun 2021 | - | $178.91 M(-18.9%) |
| Mar 2021 | - | $220.67 M(-12.0%) |
| Dec 2020 | $250.75 M(<-9900.0%) | - |
| Dec 2020 | - | $250.75 M(-6.3%) |
| Sep 2020 | - | $267.61 M(-3144.2%) |
| Jun 2020 | - | -$8.79 M |
| Dec 2019 | -$135.00 K | - |
FAQ
- What is Taysha Gene Therapies annual working capital?
- What is the all time high annual working capital for Taysha Gene Therapies?
- What is Taysha Gene Therapies annual working capital year-on-year change?
- What is Taysha Gene Therapies quarterly working capital?
- What is the all time high quarterly working capital for Taysha Gene Therapies?
- What is Taysha Gene Therapies quarterly working capital year-on-year change?
What is Taysha Gene Therapies annual working capital?
The current annual working capital of TSHA is $113.11 M
What is the all time high annual working capital for Taysha Gene Therapies?
Taysha Gene Therapies all-time high annual working capital is $250.75 M
What is Taysha Gene Therapies annual working capital year-on-year change?
Over the past year, TSHA annual working capital has changed by +$79.48 M (+236.37%)
What is Taysha Gene Therapies quarterly working capital?
The current quarterly working capital of TSHA is $132.22 M
What is the all time high quarterly working capital for Taysha Gene Therapies?
Taysha Gene Therapies all-time high quarterly working capital is $267.61 M
What is Taysha Gene Therapies quarterly working capital year-on-year change?
Over the past year, TSHA quarterly working capital has changed by +$140.86 M (+1629.62%)